Senior Director, Information Technology at Adicet Bio

Oakland, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

BS Degree in Computer Science/Engineering, Information Technology or related field of study
At least 10 years of progressive experience in IT management, preferably within a fast-paced biotech environment
Experience managing functions such as information systems, computer operations, network systems, data warehousing, telecommunications, enterprise wide systems, applications programming and internal systems programming
Experience overseeing the acquisition and maintenance of enterprise IT equipment
Knowledge of life sciences industry and the drug development process
Demonstrated experience in contingency planning, disaster preparedness, and development of policies supporting regulatory requirements
A “no job is too small” attitude, with a willingness to serve as a helpdesk contact for employees and develop a strategic, long-term vision for the company’s IT systems
Ability to provide practical, business-oriented solutions
Ability to analyze and communicate complex IT issues and solutions to non-technical stakeholders
Demonstrated alignment with Aditum Bio’s values: Collaborative, Curious, Courageous and Patient-Centric

Responsibilities

Ensure that information technology infrastructure is available, secure and compliant, enabling seamless business continuity and efficiency for the company and its associates
Oversee the implementation and maintenance of critical systems such as Azure Active Directory, SharePoint, hardware systems and all clinical SaaS programs
Design, develop and deploy the company’s IT strategy in partnership with key internal stakeholders and external vendors
Manage IT licenses portfolio
Develop functional plans for managing information technology and security for the company, including activities to be performed in-house or through third-party relationships to best manage the company’s information systems. Evaluate opportunities for strategic outsourcing versus building internal capabilities and determine key inflection points
Provide first line support for critical systems and/or users
Work closely with internal stakeholders (e.g. Legal) to ensure compliant IT policies that support regulations such as CFR Part 11 and GDPR
Manage Aditum Bio’s IT budget

Skills

Azure Active Directory

SharePoint

IT Strategy

IT Security

System Implementation

IT Compliance

IT Infrastructure Management

Vendor Management

IT Licensing

Adicet Bio

Develops allogeneic gamma delta T cell therapies

About Adicet Bio

Adicet Bio develops cancer therapies using allogeneic gamma delta T cell therapies, which are immune cells designed to target and destroy cancer cells. Their approach utilizes donor-derived cells that are readily available, allowing for faster treatment compared to traditional methods that require a patient's own cells. The company focuses on serving healthcare providers, hospitals, and research institutions involved in cancer treatment. Adicet Bio's business model includes developing and commercializing its proprietary therapies, generating revenue through product sales and licensing agreements. A recent merger with resTORbio aims to enhance their technology and accelerate development. With significant funding, Adicet Bio is dedicated to improving cancer treatment outcomes through its unique immunotherapy approach.

Redwood City, CaliforniaHeadquarters

2014Year Founded

$141.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Paid Holidays

Parental Leave

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Wellness Program

Risks

Increased competition could impact Adicet Bio's market share.

Potential regulatory hurdles may delay clinical trials.

Financial market volatility could affect future funding rounds.

Differentiation

Adicet Bio uses allogeneic gamma delta T cells for cancer therapy.

Their therapies are 'off-the-shelf', offering faster treatment availability.

Adicet's technology includes chimeric antigen receptors for enhanced tumor targeting.

Upsides

FDA's openness to gamma delta T cell therapies could expedite approvals.

Adicet's strong financial position supports ongoing R&D efforts.

Growing market interest in gamma delta T cell therapies indicates potential collaborations.

Land your dream remote job 3x faster with AI

Try Jobo Free